Side Effects in Chemotherapy Patients
Not Applicable
- Conditions
- Health Condition 1: Z511- Encounter for antineoplastic chemotherapy and immunotherapy
- Registration Number
- CTRI/2023/10/059187
- Lead Sponsor
- Sumithra Devadiga
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients undergoing chemotherapy
Exclusion Criteria
•Patient known to be diabetics (Type 1 and/or Type 2) and were under medication for it. (Applicable for chemotherapy induced hyperglycemia)
•Patient who discontinued the treatment.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of the ADRs associated with different types of chemotherapeutic drugs and its prevalence.Timepoint: Depends on chemotherapy cycle.
- Secondary Outcome Measures
Name Time Method Secondary outcome is improvement of quality of life of patients receiving chemotherapy through management of ADR in a timely manner.Timepoint: Depends on Chemotherapy cycle